Home/Filings/4/0001567619-22-021958
4//SEC Filing

Moretti August J 4

Accession 0001567619-22-021958

CIK 0001650648other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 6:51 PM ET

Size

7.4 KB

Accession

0001567619-22-021958

Insider Transaction Report

Form 4
Period: 2022-12-21
Moretti August J
See Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-12-213,000220,060 total
    Exercise: $9.41Exp: 2029-03-19Common Stock (3,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-12-21$9.41/sh+3,000$28,2306,595 total
Footnotes (2)
  • [F1]Reflects 1,595 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
  • [F2]25% of the shares subject to the option vest on the first anniversary measured from January 7, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

4D Molecular Therapeutics, Inc.

CIK 0001650648

Entity typeother

Related Parties

1
  • filerCIK 0001344412

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:51 PM ET
Size
7.4 KB